1-20 of 30
Authors: Rohan Ramakrishna
Sort by
Journal Article
Therapeutic manipulation and bypass of the blood–brain barrier: powerful tools in glioma treatment
Alexandra M Giantini-Larsen and others
Neuro-Oncology Advances, Volume 7, Issue 1, January-December 2025, vdae201, https://doi.org/10.1093/noajnl/vdae201
Published: 15 January 2025
Journal Article
RADT-20. POSTOPERATIVE RADIOTHERAPY PROVIDES ADDITIVE PROGRESSION-FREE SURVIVAL BENEFIT IN ATYPICAL MENINGIOMAS REGARDLESS OF EXTENT OF RESECTION
Umberto Tosi and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii76, https://doi.org/10.1093/neuonc/noae165.0304
Published: 11 November 2024
Journal Article
CTIM-14. EARLY SAFETY DATA FROM A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PHASE 2B STUDY OF IGV-001, AN AUTOLOGOUS CELL IMMUNOTHERAPY, VERSUS PLACEBO, IN NEWLY DIAGNOSED GLIOBLASTOMA (NDGBM)
J Bradley Elder and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii88, https://doi.org/10.1093/neuonc/noae165.0347
Published: 11 November 2024
Journal Article
[Ga68] DOTATATE PET/MRI-guided radiosurgical treatment planning and response assessment in meningiomas
Jana Ivanidze and others
Neuro-Oncology, Volume 26, Issue 8, August 2024, Pages 1526–1535, https://doi.org/10.1093/neuonc/noae067
Published: 30 March 2024
Journal Article
CTIM-19. ONCOLYTIC DNX-2401 VIROTHERAPY PLUS PEMBROLIZUMAB IN RECURRENT GLIOBLASTOMA: A PHASE 1/2 TRIAL
Farshad Nassiri and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v65–v66, https://doi.org/10.1093/neuonc/noad179.0259
Published: 10 November 2023
Journal Article
NIMG-73. RADIOGRAPHIC CHANGES AFTER RADIATION THERAPY IN SUBTOTALLY RESECTED ATYPICAL MENINGIOMAS
Eunji Yim and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v202, https://doi.org/10.1093/neuonc/noad179.0768
Published: 10 November 2023
Journal Article
RTID-08. A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PHASE 2B STUDY OF IGV-001, AN AUTOLOGOUS CELL IMMUNOTHERAPY WITH ANTISENSE OLIGO IMV-001 TARGETING IGF-1R, VS PLACEBO, IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS
Ian Lee and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v260, https://doi.org/10.1093/neuonc/noad179.0999
Published: 10 November 2023
Journal Article
THU063 Somatostatin Analog Neoadjuvant Treatment Before Endoscopic Surgery For Growth-Hormone Producing Pituitary Adenomas Invading The Cavernous Sinus: Case Series, Systematic Literature Review And Meta-analysis
Benjamin Rapoport and others
Journal of the Endocrine Society, Volume 7, Issue Supplement_1, October-November 2023, bvad114.1143, https://doi.org/10.1210/jendso/bvad114.1143
Published: 05 October 2023
Journal Article
A multidisciplinary management algorithm for brain metastases
Alexander Ramos and others
Neuro-Oncology Advances, Volume 4, Issue 1, January-December 2022, vdac176, https://doi.org/10.1093/noajnl/vdac176
Published: 30 November 2022
Journal Article
NIMG-92. DOTATATE PET/MR-GUIDED POSTOPERATIVE RADIOTHERAPY IN SUBTOTALLY RESECTED WHO-2 MENINGIOMA: EVALUATION OF PROGRESSION-FREE SURVIVAL IN A PROSPECTIVE COHORT
Jonathan Knisely and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii186, https://doi.org/10.1093/neuonc/noac209.710
Published: 14 November 2022
Journal Article
NIMG-91. DOTATATE PET/MR-GUIDED POSTOPERATIVE MANAGEMENT IN WHO-2 MENINGIOMA: ACTIVE SURVEILLANCE BASED ON PET/MR EVIDENCE OF GROSS TOTAL RESECTION
Jonathan Knisely and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii186, https://doi.org/10.1093/neuonc/noac209.709
Published: 14 November 2022
Journal Article
SPIN-02 LEVERAGING AN MRI-GUIDED LINEAR ACCELERATOR PLATFORM FOR POST-OPERATIVE STEREOTACTIC BODY RADIATION THERAPY (SBRT) OF SPINAL METASTASES
Ariel E Marciscano and others
Neuro-Oncology Advances, Volume 4, Issue Supplement_1, August 2022, Page i11, https://doi.org/10.1093/noajnl/vdac078.043
Published: 05 August 2022
Journal Article
Utility of [18F]-fluoroestradiol (FES) PET/CT with dedicated brain acquisition in differentiating brain metastases from posttreatment change in estrogen receptor-positive breast cancer
Jana Ivanidze and others
Neuro-Oncology Advances, Volume 3, Issue 1, January-December 2021, vdab178, https://doi.org/10.1093/noajnl/vdab178
Published: 30 November 2021
Journal Article
NEIM-05. [GA68]DOTATATE PET/MRI-BASED RADIOSURGICAL RESPONSE ASESSMENT IN MENINGIOMA
Jana Ivanidze and others
Neuro-Oncology Advances, Volume 3, Issue Supplement_4, October 2021, Page iv7, https://doi.org/10.1093/noajnl/vdab112.026
Published: 21 September 2021
Journal Article
Assessing the long-term safety and efficacy of gamma knife and linear accelerator radiosurgery for vestibular schwannoma: A systematic review and meta-analysis
Sergio W Guadix and others
Neuro-Oncology Practice, Volume 8, Issue 6, December 2021, Pages 639–651, https://doi.org/10.1093/nop/npab052
Published: 13 August 2021
Journal Article
Outcomes following upfront radiation versus monitoring in atypical meningiomas: 16-year experience at a tertiary medical center
Peter C Pan and others
Neuro-Oncology Advances, Volume 3, Issue 1, January-December 2021, vdab094, https://doi.org/10.1093/noajnl/vdab094
Published: 29 June 2021
Journal Article
Outcomes of stereotactic radiosurgery for large vestibular schwannomas: a systematic review and meta-analysis
Umberto Tosi and others
Neuro-Oncology Practice, Volume 8, Issue 4, August 2021, Pages 405–416, https://doi.org/10.1093/nop/npab011
Published: 18 February 2021
Journal Article
Efficacy and comorbidities of hypofractionated and single-dose radiosurgery for vestibular schwannomas: a systematic review and meta-analysis
Umberto Tosi and others
Neuro-Oncology Practice, Volume 8, Issue 4, August 2021, Pages 391–404, https://doi.org/10.1093/nop/npab009
Published: 01 February 2021
Journal Article
[68Ga]-DOTATATE PET/MRI as an adjunct imaging modality for radiation treatment planning of meningiomas
Sean S Mahase and others
Neuro-Oncology Advances, Volume 3, Issue 1, January-December 2021, vdab012, https://doi.org/10.1093/noajnl/vdab012
Published: 21 January 2021
Journal Article
LTBK-04. PHASE 2 MULTICENTER STUDY OF THE ONCOLYTIC ADENOVIRUS DNX-2401 (TASADENOTUREV) IN COMBINATION WITH PEMBROLIZUMAB FOR RECURRENT GLIOBLASTOMA; CAPTIVE STUDY (KEYNOTE-192)
Gelareh Zadeh and others
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Page ii237, https://doi.org/10.1093/neuonc/noaa215.989
Published: 20 November 2020
Advertisement
Advertisement